Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-Prn in Patients with wet Age-Related Macular Degeneration (Wamd)

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.067
https://www.valueinhealthjournal.com/article/S1098-3015(15)02143-9/fulltext
Title : Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-Prn in Patients with wet Age-Related Macular Degeneration (Wamd)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02143-9&doi=10.1016/j.jval.2015.09.067
First page : A880
Section Title : Research Podium Presentations - Session 1
Open access? : No
Section Order : 2816
Categories :
Tags :
Regions :
ViH Article Tags :